Skip to main content
. 2010 Dec 31;45(4):247–252. doi: 10.5045/kjh.2010.45.4.247

Fig. 2.

Fig. 2

Six-year event-free survival (EFS) rate according to immunohistochemical grade. The probability of 6-year EFS for LEG patients was 92.9±6.9%, whereas that for HEG patients was 70.3±8.1%. The difference was not significant according to the log-rank test.